Search
for
Sort by
Research 421–450 of 1000+
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Adverse effects of common medications on male fertility
- Methotrexate in dermatology
- Alopecia areata: An update
- DRUG‐ASSOCIATED ALOPECIA
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus
- Alopecia areata update
- JunB defines functional and structural integrity of the epidermo-pilosebaceous unit in the skin
- The Skin in Pregnancy
- Acquired scalp alopecia. Part I: A review
- A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents
- The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome
- Pregnancy and the Skin
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Alopecia in Association with Malignancy: A Review
- Interventions for morphea
- Hair Loss in Systemic Disease
- Cicatricial alopecia
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- INTERFERONS IN DERMATOLOGY
- Tinea capitis mimicking cicatricial alopecia: What host and dermatophyte factors lead to this unusual clinical presentation?
- Evaluation of hair loss
- Expanding the Clinical and Mutational Spectrum of Recessive AEBP1-Related Classical-Like Ehlers-Danlos Syndrome
- An Update on Drug-Induced Pigmentation
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters